Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Intellia Therapeutics, Inc. (NTLA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/18/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/02/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/07/2022 |
3
| Clark Eliana (EVP, Chief Technical Officer) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 12/29/2021 |
3
| Hicks Derek (EVP, Chief Business Officer) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 07/06/2021 |
3
| BASTA JAMES (EVP, General Counsel) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 04/13/2021 |
3
| Keresty Georgia (Director) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 10/05/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/05/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/29/2019 |
3
| Sepp-Lorenzino Laura (EVP, Chief Scientific Officer) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 01/24/2019 |
3
| Cohen Fred E (Director) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 10/31/2018 |
3
| GOODMAN JESSE (Director) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 10/29/2018 |
3
| Goddard Glenn (See Remarks) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 08/10/2018 |
3
| HAYES JOHN T. (See Remarks) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 04/27/2018 |
3
| SCHIERMEIER ANDREW (See Remarks) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 03/23/2018 |
3
| Novartis Institutes for BioMedical Research, Inc. (10% Owner) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 07/25/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/25/2017 |
3
| Slaoui Moncef (Director) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 12/20/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/05/2016 |
3
| KARSEN PERRY A (Director) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 05/05/2016 |
3
| Heifner Nicole (Principal Accounting Officer) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 05/05/2016 |
3
| DORSA CAROLINE (Director) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 05/05/2016 |
3
| Haurwitz Rachel E. (10% Owner) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 05/05/2016 |
3
| GORDON CARL L (10% Owner) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 05/05/2016 |
3
| FORMELA JEAN FRANCOIS (Director) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 05/05/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/05/2016 |
3
| Rivera Jose E (Chief Operating & Legal Offr) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 05/05/2016 |
3
| Morrissey David V (Chief Technology Officer) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 05/05/2016 |
3
| LEONARD JOHN M. (Chief Medical Officer) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 05/05/2016 |
3
| Barnes Thomas M. (Chief Scientific Officer) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 05/05/2016 |
3
| Bermingham Nessan (President & CEO) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 05/05/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/05/2016 |
3
| Foresite Capital Management III, LLC (10% Owner) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 05/05/2016 |
3
| Caribou Therapeutics Holdco, LLC (10% Owner) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 05/05/2016 |
3
| Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 3 on Intellia Therapeutics, Inc. |
|
|